Modified Vaccinia Ankara-Bavarian Nordic or MVA-BN is indicated for active immunisation against smallpox, Mpox, and related orthopoxvirus infections and disease in all adults 18 years of age and older ...
The Vaccine Alliance, Gavi, and Bavarian Nordic on Wednesday announced an Advance Purchase Agreement to secure 500,000 doses of the Modified Vaccinia Ankara-Bavarian Nordic.